Re: Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center: S. Carlsson, N. Benfante, R. Alvim, D. D. Sjoberg, A. Vickers, V. E. Reuter, S. W. Fine, H. A. Vargas, M. Wiseman, M. Mamoor, B. Ehdaie, V. Laudone, P. Scardino, J. Eastham and K. Touijer J Urol 2020; 203: 1117−1121
Get full text
Journal Article
Re: Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above: A. Vickers, E. A. Vertosick, D. D. Sjoberg, M. J. Roobol, F. Hamdy, D. Neal, A. Bjartell, J. Hugosson, J. L. Donovan, A. Villers, S. Zappala and H. Lilja J Urol 2017;197:607–613
Get full text
Journal Article
Re: The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer: S. Loeb, M. G. Sanda, D. L. Broyles, S. S. Shin, C. H. Bangma, J. T. Wei, A. W. Partin, G. G. Klee, K. M. Slawin, L. S. Marks, R. H. N. van Schaik, D. W. Chan, L. J. Sokoll, A. B. Cruz, I. A. Mizrahi and W. J. Catalona J Urol 2015;193:1163–1169
Get full text
Journal Article
Re: Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer CenterS. Carlsson, N. Benfante, R. Alvim, D. D. Sjoberg, A. Vickers, V. E. Reuter, S. W. Fine, H. A. Vargas, M. Wiseman, M. Mamoor, B. Ehdaie, V. Laudone, P. Scardino, J. Eastham and K. Touijer J Urol 2020; 203: 1117-1121
Get full text
Journal Article